Quinine Sulphate Suspension

Description

Quinine Sulphate Oral Suspension (100 mg / 150 mg per 5 ml)

Healthy Inc is a specialized global supplier and exporter of advanced anti-malarials, pediatric medicine, and tropical health therapeutics. We provide ultra-high-purity, kinetically stabilized Quinine Sulphate Suspension, manufactured in WHO–GMP certified, high-precision liquid manufacturing facilities. This “Cinchona Alkaloid” is a critical strategic export to retail pharmacies, tropical disease hospitals, and government health ministries, serving as the globally preferred intervention for the treatment of Plasmodium falciparum malaria in children.

Product Overview

This formulation operates as a “Parasitic Toxin Accumulator.” It physically targets the digestive process of the malaria parasite within the human red blood cell.

• Mechanism 1 (Heme Detoxification Inhibition): The malaria parasite consumes hemoglobin and releases toxic “Heme.” Quinine physically prevents the parasite from converting this toxin into harmless “Hemozoin” crystals.

• Mechanism 2 (Parasitic Poisoning): The resulting accumulation of free heme physically poisons the parasite, leading to its rapid death.

• Mechanism 3 (Schizonticidal Action): It physically acts on the Erythrocytic (Blood) Stage of the infection, which is responsible for the clinical symptoms of fever and chills.

Product Composition & Strength

We supply this product as a Micronized Homogeneous Suspension, ensuring maximum bioavailability and consistent dosing.

Technical & Logistics Specifications

• HS Code: 3004.20.19 (Medicaments containing other antibiotics / Anti-malarials)

• CAS Number: 6119-70-7 (Quinine Sulphate)

• Dosage Form: Oral Liquid (Suspension)

• Packaging: 60 ml / 100 ml Amber PET or Glass Bottles. Our specialized packaging ensures 36-month stability in Zone IVb tropical climates.

Manufacturing Authority & Compliance

• High-Shear Homogenization: Quinine Sulphate is physically insoluble. Our manufacturing process utilizes Advanced Homogenization to ensure the drug is perfectly micronized, preventing “caking” at the bottom of the bottle.

• Bitterness Masking: Quinine is physically one of the most bitter substances known. We utilize Specialized Taste-Masking Agents and high-quality sweeteners to ensure pediatric compliance.

• Aseptic Liquid Filling: We utilize Automated Liquid Filling Lines with 100% microbial testing to ensure total safety for children with compromised immune systems.

Primary Indications

• Pediatrics: Treatment of Severe or Uncomplicated Malaria caused by P. falciparum.

• Tropical Medicine: Management of Chloroquine-Resistant Malaria in endemic regions.

• Critical Care: Oral follow-up therapy after initial intravenous Quinine treatment.

Dosage & Administration

• Standard Regimen: Typically 10 mg/kg body weight administered every 8 hours for 7 days.

• Administration: For maximum safety and to reduce potential gastric upset, it should physically be taken with or after food.

• Shake Well: The bottle must be physically shaken before each use to ensure uniform drug distribution.

Safety Warning: For Oral Use Only. Cinchonism Note: Physicians must physically monitor for signs of Cinchonism (tinnitus/ringing in ears, headache, nausea, and blurred vision). Heart Note: Quinine can physically affect the QT Interval; use with caution in children with heart rhythm disorders. Contraindication: Do not use in patients with known hypersensitivity to Quinine, G6PD deficiency, or optic neuritis.

Global Export & Contract Manufacturing

Healthy Inc is a premier Anti-Malarial and Pediatric Pharmaceutical Exporter in India. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) for high-volume anti-malarial suspensions. Whether you are a National Malaria Program in Sub-Saharan Africa or a B2B Pharma Marketplace partner in SE Asia or the Middle East, we ensure secure, WHO-GMP compliant delivery.